Please check your internet connection and try again.
# Arsil-dx
## Overview
Arsil-dx is a combination product typically containing **guaifenesin** (expectorant) and **dextromethorphan hydrobromide** (antitussive). It is formulated to manage cough and respiratory congestion associated with the common cold, bronchitis, or upper respiratory tract infections.
## Primary Indications
Symptomatic relief of cough due to minor throat and bronchial irritation and temporary relief of chest congestion by thinning bronchial secretions.
## Adult Dosing
* **Standard Dose:** 10–20 mL (or 1-2 tablets depending on formulation concentration) orally every 4 to 6 hours as needed.
* **Maximum Dose:** Do not exceed 120 mL (or equivalent based on formulated concentration) in 24 hours.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mL orally every 4 to 6 hours. Maximum: 60 mL per 24 hours.
* **Children under 6 years:** Not recommended without direct physician supervision; avoid due to high risk of adverse events and lack of efficacy data in infants/toddlers.
* *Note:* Always use the calibrated measuring device provided with the product.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific manufacturer-defined adjustments; however, use with caution in patients with severe impairment as metabolic clearance may be altered.
* **Geriatric:** Caution advised; start at the lower end of the dosing range due to increased risk of dizziness or confusion.
## Contraindications
* Hypersensitivity to any component (guaifenesin, dextromethorphan).
* Concurrent use or use within 14 days of **MAO inhibitors (MAOIs)** due to the risk of serotonin syndrome.
* Persistent or chronic cough associated with asthma, emphysema, or smoking.
## Adverse Effects
* **Common:** Dizziness, drowsiness, nausea, vomiting, stomach pain, or constipation.
* **Serious:** Serotonin syndrome (if used with serotonergic agents), confusion, visual hallucinations, or skin rash.
## Key Drug Interactions
* **MAOIs (e.g., phenelzine, selegiline):** Life-threatening hypertensive crisis or serotonin syndrome.
* **CNS Depressants (e.g., alcohol, benzodiazepines, opioids):** Additive sedative effects.
* **Serotonergic Agents (e.g., SSRIs, SNRIs):** Increased risk of serotonin syndrome.
## Monitoring
* Monitor for symptom relief and duration of cough; discontinue if cough persists >7 days or is accompanied by high fever, rash, or persistent headache.
* Monitor for signs of CNS depression or paradoxical excitation in pediatric patients.
## Clinical Pearls
* **Hydration:** Emphasize the importance of adequate fluid intake while taking guaifenesin to help loosen phlegm/secretions effectively.
* **Combination Safety:** Check for "tuck-in" ingredients in multi-symptom cold products (e.g., acetaminophen or antihistamines) to prevent accidental overdose or duplicative therapy.
* **Drug Testing:** Dextromethorphan is structurally related to codeine and may trigger false-positive results on some qualitative urine drug screens.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical dosing may vary based on local protocols, brand-specific concentrations, and patient-specific factors. Always verify the current prescribing information, package insert, and institutional guidelines before administering any medication.
